Ignite Creation Date:
2024-05-06 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05222165
Status:
WITHDRAWN
Last Update Posted:
2023-02-23
First Post:
2022-01-12
Brief Title:
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations
Sponsor:
Helsinn Healthcare SA
Organization:
Helsinn Healthcare SA
Organization Data
Organization:
Helsinn Healthcare SA
Class:
INDUSTRY
Study ID:
INFI-21-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Helsinn Healthcare SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Labcorp Corporation of America Holdings Inc | INDUSTRY |